Psagot Value Holdings’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,579
Closed -$1.33M 399
2020
Q4
$1.33M Sell
10,579
-456
-4% -$51K 0.03% 161
2020
Q3
$1.12M Sell
11,035
-2,117
-16% -$216K 0.03% 162
2020
Q2
$1.28M Sell
13,152
-2,007
-13% -$187K 0.04% 134
2020
Q1
$1.26M Sell
15,159
-19,605
-56% -$1.91M 0.05% 126
2019
Q4
$3.86M Buy
34,764
+3,164
+10% +$325K 0.13% 106
2019
Q3
$3.14M Buy
31,600
+1,800
+6% +$179K 0.13% 105
2019
Q2
$2.96M Buy
29,800
+10,000
+51% +$954K 0.12% 110
2019
Q1
$2.18M Buy
19,800
+6,300
+47% +$658K 0.09% 125
2018
Q4
$1.24M Buy
+13,500
New +$1.37M 0.06% 156

Other funds holding PRAH

Psagot Value Holdings's PRAH Position: Q1 2021 in Review

Psagot Value Holdings sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 10,579 shares — an estimated $1.33M sold.

Psagot Value Holdings first reported a position in PRAH in Q4 2018 and held it in 9 quarters. The position peaked at $3.86M in Q4 2019. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Psagot Value Holdings reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Psagot Value Holdings sold 10,579 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $1.33M.
  • Psagot Value Holdings first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 9 quarters.
  • Psagot Value Holdings's PRA Health Sciences, Inc. position peaked at $3.86M in Q4 2019.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Psagot Value Holdings's 13F filing for Q1 2021, filed 18 May 2021.